Press Release

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Cytokine Market to Grow at a CAGR of 6% in the Forecast Period of 2022-2027, Aided by the Increasing Prevalence of Chronic Diseases

According to a new report by EMR titled, ‘Global Cytokine Market Report and Forecast 2022-2027’, the global cytokine industry is expected to grow at a CAGR of 6% in the forecast period of 2022-2027.

The cytokine market is predicted to increase in response to the rising prevalence of diseases such as cancer and skin ailments. They also contribute to the body's anti-cancer activities by transmitting signals that cause aberrant cells to perish and regular ones to live longer. The cytokines market is developing due to the rising demand for regenerative treatments. The cytokines market is predicted to develop due to the increasing demand for cytokines in stem cell biology and growing cell culture-based research activities. Because of the increasing number of diagnostics, therapeutic, and preventive applications of cytokines in various healthcare institutions across the world, the market is booming. This is largely owing to excellent chemical cytokine synthesis, which allows for high-quality vaccine manufacture and the development of additional therapeutic processes for various diseases. The rising number of cancer patients and the huge investments by the governments in the healthcare industry is propelling the growth of the market. Cytokine is finding increasing acceptance in cancer therapy over the world. Application in cancer is expected to hold the largest share of the market. Cytokine, when mixed with any vaccine, can enhance that vaccine’s effectiveness, therefore, bolstering the growth of the market. Cytokine boosts anti-cancer activity by sending signals that can help make abnormal cells die and normal cells live longer hence enhances the growth of the market.

Merck KGaA (NASDAQ: MKGAF), one of the leading players of the market, has entered into a global strategic alliance with GlaxoSmithKline plc (GSK) to co-develop and co-commercialise the Merck KGaA’s next-generation immunotherapy candidate, M7824 (bintrafusp alfa), that has potential in different difficult-to-treat cancers.

Market Analysis by Type, Applications, and Regions:

  • Based on type, the market is divided into tumour necrosis factor – TNF, interleukins – II, interferons – IFN, and epidermal growth factor – EGF, among others.
  • Based on therapeutic application, the market is divided into cancer, asthma and airway inflammation, and arthritis, among others.
  • The regional markets for cytokine include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • With the advent of new technologies, the cytokine industry is expected to grow over the forecast period.
  • Increasing research and development activities in the field of drug development and life sciences is propelling the market growth.
  • The growing demand for cytokine for wound management and cancer therapeutics is expected to drive market growth.
  • The increasing number of pharmaceutical manufacturers, biotechnology companies, and academic institutions are expected to boost market growth.

Key Offerings of the report:

  • The EMR report gives an overview of the cytokine market for the periods (2017-2021) and (2022-2027).   
  • The report also offers the historical (2017-2021) and forecasted (2022-2027) markets for type, therapeutic application, and major regions of the cytokine.   
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global cytokine market are F. Hoffmann-La Roche Ltd, Merck KGaA, Lonza Group Ltd, Abcam plc., Genscript Biotech Corporation, and Randox Laboratories Ltd., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER